These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12947218)

  • 21. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) unstable angina/non-ST elevation myocardial infarction critical pathway toolkit.
    Cannon CP;
    Crit Pathw Cardiol; 2008 Mar; 7(1):43-81. PubMed ID: 18458666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of results of percutaneous coronary intervention for non-ST-elevation acute myocardial infarction or unstable angina pectoris in men versus women.
    Elkoustaf RA; Mamkin I; Mather JF; Murphy D; Hirst JA; Kiernan FJ; McKay RG
    Am J Cardiol; 2006 Jul; 98(2):182-6. PubMed ID: 16828589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of non-ST-Segment Elevation Myocardial Infarction.
    Van Horn SE; Maniu CV
    Med Clin North Am; 2007 Jul; 91(4):683-700; xi. PubMed ID: 17640542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
    Bolognese L
    Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key articles and guidelines in the management of acute coronary syndromes and in percutaneous coronary intervention: 2007 update.
    Dobesh PP; Brouse SD; Dager WE; Spinler SA; Stacy Z; Wiggins BS
    Pharmacotherapy; 2007 Dec; 27(12):1722-58. PubMed ID: 18041892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
    Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA
    J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-ST-Segment elevation acute coronary syndrmes: management strategies for optimal outcomes.
    Housholder-Hughes SD
    Crit Care Nurse; 2006 Feb; Suppl():8-10, 12, 14 passim; quiz 36. PubMed ID: 16671386
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report.
    Cohen M; Diez J; Fry E; Rao SV; Ferguson JJ; Zidar J; Levine G; Shani J
    J Invasive Cardiol; 2006 Dec; 18(12):617-39. PubMed ID: 17197714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary syndromes.
    Elmouchi DA; Bates ER
    Minerva Cardioangiol; 2003 Oct; 51(5):547-60. PubMed ID: 14551523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade.
    Levine GN; Lincoff AM; Ferguson JJ; Mahaffey KW; Goodman SG; Cannon CP; Theroux P; Fox KA
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):149-57. PubMed ID: 16152646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes.
    Collet JP; Montalescot G; Golmard JL; Tanguy ML; Ankri A; Choussat R; Beygui F; Drobinski G; Vignolles N; Thomas D
    Am Heart J; 2004 Apr; 147(4):655-61. PubMed ID: 15077081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
    MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prognostic stratification in non-ST-elevation acute coronary syndromes: how and why].
    Greco C; Luongo R
    G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):7S-12S. PubMed ID: 16749286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk stratifying the acute coronary syndrome patient: a focus on treatable risk.
    Steinhubl SR
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S3-8. PubMed ID: 17917619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification.
    Oliveira GB; Avezum A; Anderson FA; Budaj A; Dabbous OH; Goodman SG; Steg PG; Goldberg RJ; Brieger D; Fox KA; Gore JM; Granger CB;
    Am Heart J; 2007 Apr; 153(4):493-9. PubMed ID: 17383284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous coronary intervention: recommendations for good practice and training.
    Dawkins KD; Gershlick T; de Belder M; Chauhan A; Venn G; Schofield P; Smith D; Watkins J; Gray HH;
    Heart; 2005 Dec; 91 Suppl 6(Suppl 6):vi1-27. PubMed ID: 16365340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.